Tori (Florence) Guerina

(she/her)

Tori is a PhD student in the Molecular Cell Biology and Biochemistry program at Boston University.

Tori obtained an Associates degree in Biotechnology from North Shore Community College where she was awarded the Daniel Rourke Memorial Scholarship. She went on to obtain a B.S. in Biology with Honors from the University of Massachusetts Lowell, where she explored various avenues of research from stem cell biology to entomology. Her projects included histological analysis of the giant whip scorpion Mastigoproctus giganteus and an honors thesis where she used human colon cancer cell lines to perform pre-clinical testing of polymer-based therapies for metabolic disease. After graduation, Tori was hired as a research associate at Glyscend Therapeutics where she continued to work on treatments for Type-2 Diabetes, focusing on a novel drug that is currently undergoing clinical trials. Tori started at BU as a PhD student in 2022 and joined the Younger Lab to conduct her thesis research in 2023. Tori was selected as a 2023 trainee in BU's NIH T32 Synthetic Biology and Biotechnology (SB2) Training Program.